发明名称 Positive allosteric modulators of the α7 nicotinic acetylcholine receptor and uses thereof
摘要 The present invention relates to compounds useful in the positive modulation of the alpha 7 nicotinic acetylcholine receptor (α7nAChR). The invention also relates to the use of these compounds in the treatment or prevention of a broad range of diseases in which the positive modulation of α7nAChR is advantageous, including neurodegenerative and neuropsychiatric diseases and also inflammatory diseases.
申请公布号 US9062013(B2) 申请公布日期 2015.06.23
申请号 US201213983476 申请日期 2012.02.02
申请人 Bionomics Limited 发明人 Harvey Andrew;Fluck Audrey;Giethlen Bruno;Paul Dharam;Schaeffer Laurent
分类号 C07D213/75;C07D231/40;C07D277/46;C07C311/46;C07C233/60;A61K31/44;A61K31/167;A61K31/36;A61K31/63;C07C233/59;C07C311/16;C07D317/46;C07D275/06;C07D209/46 主分类号 C07D213/75
代理机构 Honigman Miller Schwartz & Cohn LLP 代理人 Honigman Miller Schwartz & Cohn LLP ;Wootton, Esq. Thomas A.;O'Brien Jonathan P.
主权项 1. A compound of formula (I) or a salt thereof: wherein R1 is selected from optionally substituted aryl, optionally substituted heteroaryl (excluding optionally substituted porphyrins), or optionally substituted heterocyclyl; R2 is selected from C1-C4 alkyl, C3-C5 alkenyl, F, Br, Cl, CN, or C1-C4 haloalkyl; R3 is selected from hydrogen, C1-C4 alkyl, C3-C5 alkenyl, F, Br, Cl, CN, or C1-C4 haloalkyl; orR2 and R3 together form C4-9 cycloalkyl or C4-9 cycloalkenyl;R4 is selected from optionally substituted heteroaryl, optionally substituted heterocyclyl, or optionally substituted aryl;R5 is selected from hydrogen or optionally substituted alkyl;wherein when both R2 and R3 are Cl, R4 is an optionally substituted heteroaryl or optionally substituted heterocyclyl, andprovided that the following compounds are excluded:
地址 Thebarton AU